Literature DB >> 27193907

On- versus off-hour care for patients with non-ST-segment elevation myocardial infarction in Germany : Exemplary results within the chest pain unit concept.

F Breuckmann1, F Remberg2, D Böse2, J Waltenberger3, D Fischer3, T Rassaf4.   

Abstract

AIM: The aim of this study was to analyze differences in the timing of invasive management of patients with high-risk acute coronary syndrome without persistent ST-segment elevation (hr-NSTE-ACS) or myocardial infarction without persistent ST-segment elevation (NSTEMI) between on- and off-hours in a German chest pain unit (CPU). PATIENTS AND METHODS: We retrospectively enrolled 160 NSTEMI patients in the study, who were admitted to two German CPUs in 2013. Patients presenting on weekdays between 8 a.m. and 6 p.m. were compared with patients presenting during off-hours. Data analysis included time intervals from admission to invasive management (goals: for hr-NSTE-ACS, <2 h; for NSTEMI, <24 h) and the resulting guideline adherence.
RESULTS: Guideline-adherent timing of an invasive strategy did not differ significantly between the on-hour (6.5 h [3.0-22.0 h], 79.9 %) and off-hour groups (10.5 h [2.0-20.0 h], 75.3 %; p = 0.94), without additional significant differences between admissions during off-hours Monday to Thursday and weekends (10.0 h [2.0-19.0 h], 75.6 % vs. 7.5 h [2.0-20.0 h], 76.2 %; p = 0.96).
CONCLUSION: Our exemplary experience in two different German CPUs demonstrates adequate timing of coronary catheterization in over 75 % of cases, irrespective of admission during on- or off-hours. Nationwide validation of our findings by the German CPU registry is mandatory.

Entities:  

Keywords:  Chest pain unit; Coronary angiography; Hospitalization; Myocardial infarction, non-ST segment elevation; Patient admission

Mesh:

Year:  2016        PMID: 27193907     DOI: 10.1007/s00059-016-4425-5

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  24 in total

1.  The off-hours paradigm in primary PCI can be overcome by a uniform regional treatment protocol.

Authors:  Ralf Birkemeyer; Andreas Rillig; Tomislav Miljak; Udo Meyerfeldt; Erhard Kaiser; Werner Jung; Jochen Wöhrle
Journal:  Int J Cardiol       Date:  2012-04-17       Impact factor: 4.164

2.  High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission.

Authors:  Evangelos Giannitsis; Meike Becker; Kerstin Kurz; Georg Hess; Dietmar Zdunek; Hugo A Katus
Journal:  Clin Chem       Date:  2010-02-18       Impact factor: 8.327

3.  ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC).

Authors:  Christian W Hamm; Jean-Pierre Bassand; Stefan Agewall; Jeroen Bax; Eric Boersma; Hector Bueno; Pio Caso; Dariusz Dudek; Stephan Gielen; Kurt Huber; Magnus Ohman; Mark C Petrie; Frank Sonntag; Miguel Sousa Uva; Robert F Storey; William Wijns; Doron Zahger
Journal:  Eur Heart J       Date:  2011-08-26       Impact factor: 29.983

4.  Pre- and early in-hospital procedures in patients with acute coronary syndromes: first results of the "German chest pain unit registry".

Authors:  Felix Post; Evangelos Giannitsis; Thomas Riemer; Lars S Maier; Claus Schmitt; Burghard Schumacher; Gerd Heusch; Harald Mudra; Thomas Voigtländer; Rainer Erbel; Harald Darius; Hugo Katus; Christian Hamm; Jochen Senges; Tommaso Gori; Thomas Münzel
Journal:  Clin Res Cardiol       Date:  2012-07-25       Impact factor: 5.460

5.  Optimal timing of invasive angiography in stable non-ST-elevation myocardial infarction: the Leipzig Immediate versus early and late PercutaneouS coronary Intervention triAl in NSTEMI (LIPSIA-NSTEMI Trial).

Authors:  Holger Thiele; Justus Rach; Norbert Klein; Dietrich Pfeiffer; Andreas Hartmann; Rainer Hambrecht; Peter Sick; Ingo Eitel; Steffen Desch; Gerhard Schuler
Journal:  Eur Heart J       Date:  2011-11-21       Impact factor: 29.983

6.  Establishment and progress of the chest pain unit certification process in Germany and the local experiences of Mainz.

Authors:  Felix Post; Tommaso Gori; Jochen Senges; Evangelos Giannitsis; Hugo Katus; Thomas Münzel
Journal:  Eur Heart J       Date:  2012-03       Impact factor: 29.983

7.  Timing of percutaneous coronary intervention in troponin-negative patients with acute coronary syndrome without persistent ST-segment elevation: preliminary results and status quo in German chest pain units.

Authors:  Frank Breuckmann; Matthias Hochadel; Thomas Münzel; Evangelos Giannitsis; Thomas Voigtländer; Jochen Senges
Journal:  Crit Pathw Cardiol       Date:  2015-03

8.  Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome.

Authors:  Fred S Apple; Stephen W Smith; Lesly A Pearce; Ranka Ler; Maryann M Murakami
Journal:  Clin Chem       Date:  2008-01-31       Impact factor: 8.327

9.  Weekend versus weekday admission and mortality from myocardial infarction.

Authors:  William J Kostis; Kitaw Demissie; Stephen W Marcella; Yu-Hsuan Shao; Alan C Wilson; Abel E Moreyra
Journal:  N Engl J Med       Date:  2007-03-15       Impact factor: 91.245

10.  Non-ST-elevation myocardial infarction patients who present during off hours have higher risk profiles and are treated less aggressively, but their outcomes are not worse: a report from Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation of the ACC/AHA Guidelines CRUSADE initiative.

Authors:  Charles V Pollack; Judd E Hollander; Anita Y Chen; Eric D Peterson; Sripal Bangalore; Frank W Peacock; Christopher P Cannon; John G Canto; Brian W Gibler; Magnus E Ohman; Matthew T Roe
Journal:  Crit Pathw Cardiol       Date:  2009-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.